The backbone behind our protective and reparative benefits is the ProVention-R™ Ingredient Library -- comprised of the most effective doctor-selected ingredients.
Cutting edge technology is important to us. Just take a look at our patented SolSci-X™ - stabilization for chemical sunscreen systems without the use of oxybenzone or octinoxate.
The Skin Health Exchange (S.H.E.) is the education arm of MDSolarSciences™ and brings you advice, ideas and insight from our distinguished SAC.
Robert J. Friedman, M.D., M.Sc. (Med.)
Dr. Robert J. Friedman is a practicing dermatologic oncologist in New York City and Clinical Professor at the New York University (NYU) School of Medicine, Department of Dermatology. A graduate of the Albert Einstein College of Medicine, he received the M.D. degree in May 1978. He completed a pre-doctoral fellowship in Experimental Pathology at the McMaster University, Faculty of Medicine, and an M.Sc. in Medical Sciences in 1975. He did his residency and fellowship training at the NYU School of Medicine and Bellevue Hospital and Medical Center in Anatomic Pathology, Dermatopathology and Dermatology. He was the National Institutes of Health Melanoma Fellow at NYU from 1980-1982.
He has written more than 200 peer-reviewed medical journal articles, 30 medical textbook chapters and served as Senior Editor/Co-Editor of the seminal textbook Cancer of the Skin. He has conducted global/national seminars, including the Melanoma and Clinical Oncology Symposium at the American Academy of Dermatology (AAD) annual meetings. He has served on the Melanoma/Skin Cancer Committee and Industry Liaison Committee of the AAD, and as Chairman and CEO of Dermpath, Inc. and PathSOURCE, Inc. and as Vice Chair of Inform DX.
Dr. Friedman’s expertise is in cancers of the skin, notably in clinically diagnosing and managing malignant melanoma and related lesions. At the NYU Melanoma Cooperative Group, he and colleagues originated the “ABCDs” of clinical diagnosis and self-examination of the skin as an adjunct to early detection. He is on the Scientific Advisory Board of Electro-Optical Sciences and developer of Melafind–an instrument to help diagnose melanoma, which is in Phase III clinical trials by the U.S. Food and Drug Administration. He also heads the Institute for Melanoma/Skin Cancer Research, Inc. and MDHealthPARTNERS, which funds and consults to small cancer-related companies.
His main interest is in the clinical care of patients with cancers of the skin. He has dedicated himself to helping to prevent death from melanoma through medicinal techniques, early detection and therapeutic intervention, while the search for a cure goes on.
scientific advisory council
The Scientific Advisory Council (SAC) plays an integral role at MDSolarSciences™. It expands, by extraordinary proportions, the company’s bench strength in medical/scientific specialties. The members of the SAC support a range of activities. These include helping to develop and review products as well as create educational programs. The SAC also fine-tunes product specifications and performance standards. The SAC roster includes these leading medical professionals:
MDSolarSciencesTM Chief Science Advisor
Volunteer Associate Professor Dept. of Dermatology & Cutaneous Surgery
University of Miami
Miller School of Medicine
Ronald R. Brancaccio
Dir. The Skin Institute of New York
Clinical Professor of Dermatology
NYU School of Medicine
Diane S. Berson
Associate Clinical Professor of Dermatology
Weill Medical College of Cornell University
New York Presbyterian Hospital
Patrice M. Healey
Assistant Clinical Professor of Medicine
David Geffen UCLA School of Medicine Los Angeles, CA
Clinical Assistant Professor
NYU-Langone Medical School
Clinical Associate Professor of Dermatology
NYU Langone Medical Center
Dermatology Surgeon / Oncology University of Miami
Ophthamology / Retina North Shore LIJ
Assistant Clinical Professor
Department of Dermatology
Mount Sinai Medical Center
University of Miami